Visual and motor evoked potentials in the course of multiple sclerosis

Brain

Volumn 124, Issue 11, 2001, Pages 2162-2168

  Fuhr, Peter ^a,c   Borggrefe Chappuis, A ^a   Schindler, C ^b   Kappos, L ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Electrophysiology; Magnetic resonance imaging; Motor evoked potentials; Multiple sclerosis; Visual evoked potentials

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; EVOKED MUSCLE RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE;

EID: 0035173632     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.11.2162     Document Type: Article

References (38)

1. Serial evoked potential studies in patients with definite multiple sclerosis. Clinical relevance
2. Evoked potentials to test a treatment of chronic multiple sclerosis
3. A comparison of motor evoked potentials and somatosensory evoked potentials in patients with multiple sclerosis and potentially related conditions
4. Serial pattern shift visual evoked potentials in multiple sclerosis
5. Diagnostic value of paraclinical tests in multiple sclerosis: Relative sensitivities and specificities for reclassification according to the Poser Committee criteria
6. The pattern visual evoked potential. A multicenter study using standardized techniques
7. Long-term remyelination after optic neuritis. A 2-year visual evoked potential and psychophysical serial study
8. Evoked potentials in clinical medicine (second of two parts.)
9. Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis
10. Measuring evoked responses in multiple sclerosis
11. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis
12. Evoked potentials in clinical trials for multiple sclerosis
13. Motor evoked potentials and disability in secondary progressive multiple sclerosis
14. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis
15. Electrocutaneous reflexes and multimodality evoked potentials in multiple sclerosis
16. Measurement of central motor conduction in multiple sclerosis by magnetic brain stimulation
17. Magnetic brain stimulation: Central motor conduction studies in multiple sclerosis
18. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
19. The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis
20. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis
21. Multimodality evoked potentials and blink reflex in multiple sclerosis
22. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
23. Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis
24. 'Normalisierung' des VEP bei multipler sklerose? Verlaufsbeobachtung bei 50 von 500 MS-patienten
25. Serial recording of visual and somato-sensory evoked potentials in multiple sclerosis
26. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
27. Evoked potentials predict the clinical changes in a multiple sclerosis drug study
28. Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis
29. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
30. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
31. Sensory (VEP, BAEP, SEP) and motor-evoked potentials, liquoral and magnetic resonance findings in multiple sclerosis
32. Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis
33. Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis
34. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis
35. Evoked potential changes in clinically definite multiple sclerosis: A two year follow up study
36. Clinical course and electrophysiology of multiple sclerosis